The idea that histone methylation contributes to the full activation potential of nuclear hormone receptors came from the finding of Chen et al.
The genetic information of each eukaryotic organism is embedded in the context of chromatin, a complex structure that not only serves to compact the genome but plays a major role in the regulation of gene expression in vivo [1] . Chromatin is formed by the association of a 147 base-pair stretch of DNA with a histone octamer formed by two molecules of each of the four core histones, H2A, H2B, H3 and H4 [2] . This nucleosomal structure is the basic building block of chromatin. Adjacent nucleosomes can fold into higherorder structures, which can restrict the accessibility of DNA to binding factors, such as basal and specific transcription factors and RNA polymerases. The posttranslational modification of the histone aminoterminal tails can increase or further decrease the accessibility of DNA within chromatin; I will refer to these two states as 'open' or 'closed' chromatin configurations, respectively.
The many potential histone modifications, which in principle can occur in a large number of combinations (Figure 1 ), inspired a model in which a specific set of modifications form a kind of 'epigenetic code'. The postulated code can have a very specific functional output: for example, increased transcription or the formation of particular chromatin structures such as the centromere (reviewed in [3, 4] ). Several groups have already shown that histone modifications, such as acetylation or ubiquitination, can substantially influence the likelihood of further modifications, such as phosphorylation or methylation [5] [6] [7] [8] [9] . But the exact order of the histone modifications made during transcriptional activation or repression has not been addressed in detail.
In an elegant study published recently in Current Biology, Daujat et al. [10] used the estrogen-responsive promoter of the presenillin 2 gene (pS2) to study the appearance of histone modifications during gene activation. The pS2 gene is well-known to be estrogenresponsive, and the kinetics of its activation and of estrogen receptor and transcriptional cofactor binding to the promoter have been well characterised [11] . This seems to be a particularly good system for such a study, as it can easily be controlled experimentally by addition of its natural ligand 17β β estradiol. Upon ligand binding, estrogen receptor molecules bind to estrogenresponse elements (EREs) within the promoters of estrogen-responsive genes. The promoter-bound receptor molecules recruit a variety of cofactors, which in turn modify the chromatin structure at the promoter and also attract the basal transcriptional machinery (Figure 2 ).
These transcriptional coactivators fall into distinct classes. One class consists of the nucleosome remodelling activities BRM/SNFα α and BRG1/SNFβ β, , which use the hydrolysis of ATP to reorganise chromatin structure [12] . The second class consists of histone acetyltransferases such as CBP, p300 and P/CAF, which are thought either to directly change higher-order chromatin folding or to act as 'tagging' factors which mark a particular region of the genome [13] . Another group of cofactors is the p160 family, which serve as adaptor molecules to strengthen further the interaction between the estrogen receptor and the transcriptional coactivators mentioned above [14] .
The idea that histone methylation contributes to the full activation potential of nuclear hormone receptors came from the finding of Chen et al. [15] that a protein, which they termed coactivator associated arginine methyltransferase 1 (CARM1), can interact specifically with members of the p160 coactivator family (in a yeast two-hybrid screen at least). CARM1, which shows significant sequence similarity to known arginine methyltransferases, is able to methylate histone H3 at positions 17 and 26, and this methyltransferase activity is essential for its ability to act as a coactivator [15] . Histone H3 methylated at arginine 17 is indeed found to be enriched on hormone responsive promoters after induction [16, 17] . CARM1 acts synergistically with other known coactivators, such as the acetyltransferases p300 and P/CAF [18] , suggesting that histone methylation and histone acetylation work together to stimulate transcription to the full extent.
In the breast cancer cell line MCF7, induction of the pS2 promoter by estrogen leads to an increased synthesis of presenillin RNA, which is first detectable 15 minutes after hormone induction and continues to increase for at least another 45 minutes. In their recent work, Daujat et al. [10] analysed the change in histone modifications during the first 60 minutes of transcriptional activation, using antibodies directed against specifically modified histones. Interestingly, they found that, even in the absence of hormone, lysine 14 of histone H3 is already acetylated, and the levels of lysine 14 acetylation do not change during the time course of the experiment.
The first detectable sign of coactivator function on the presenillin promoter is acetylation of lysine 18 of histone H3, which is found 15 minutes after hormone induction. This acetylation in all likelihood results from recruitment of the histone acetyltransferase CBP by the estrogen receptor, as it can be mimicked by overexpression of CBP in the absence of ligand. Methylation of arginine 17 of histone H3, shown previously to be associated with the transcriptionally active presenillin promoter [16] , is detected only 30 minutes after hormone induction, together with the acetylation of lysine 23, which appears only transiently at the promoter when it is fully active.
These results indicate that histone modifications at the induced pS2 promoter are highly interdependent and formed in a stepwise manner. They also suggest that the acetylation of lysine 18 is required for CARM1 mediated methylation. Indeed, in vitro methylation experiments by Daujat et al. [10] , using recombinant CARM1, showed increased methylation of histones that were pre-acetylated by p300, as well as of chemically synthesised peptides carrying an acetylated lysine at position 18. This dependency might reflect the increased substrate affinity of CARM1 for the acetylated versus the unmodified peptide.
It is very tempting to speculate about the possible benefits of this specific modification pattern at the pS2 promoter. One could imagine that the methylation of arginine 17 might serve as a mark that this promoter has previously been activated. Alternatively, methylation at lysine 17 might increase the efficiency of nucleosome remodelling and transcriptional reinitiation by generating a specific recognition site for the corresponding factors (see Figure 2) . 
